Common Conditions in Pregnancy — Clinical Documentation Guide (2026)

🔍 Definition

Pregnancy-related conditions span a broad spectrum of obstetric complications documented under ICD-10-CM Chapter 15 (O00–O9A) and supplementary Z-codes. This guide covers the most commonly coded conditions encountered in antepartum, intrapartum, and postpartum encounters, including hypertensive disorders of pregnancy (HDP) (O10–O16), gestational diabetes mellitus (GDM) (O24), venous complications (O22), genitourinary infections (O23), and a range of other maternal conditions (O26, O28, O34, O36, O40–O45, O99, Z3A, Z34). Accurate coding requires precise documentation of the condition, its severity, the trimester, and whether the disorder is pre-existing or pregnancy-induced.

Per CMS FY2026 ICD-10-CM Official Guidelines Section I.C.15, Chapter 15 codes take priority for pregnant patients when the condition is complicating or is affected by the pregnancy, with the principal diagnosis being the condition that prompted the encounter.

🗂️ Alternative Terminology

🩺 Signs & Symptoms

Clinical presentations vary significantly across the spectrum of pregnancy complications. Key findings documented in the medical record drive code assignment:

• HDP (O10–O16): Elevated BP ≥140/90 mmHg; proteinuria (≥300 mg/24h or PCR ≥0.3); thrombocytopenia, elevated LFTs, impaired renal function, new-onset headache, visual disturbances, epigastric pain (preeclampsia with severe features); seizures (eclampsia). HELLP: Hemolysis, Elevated Liver enzymes, Low Platelets.
• GDM (O24.4x): Abnormal 1-hour GCT (≥140 mg/dL) and/or 3-hour GTT; hyperglycemia; fetal macrosomia on ultrasound. Often asymptomatic.
• Venous complications (O22.x): Visible/palpable dilated superficial veins in legs, vulva, or anus; localized pain, warmth, erythema over a vein (thrombophlebitis); DVT: unilateral leg swelling, calf pain, Homan’s sign.
• GU infections (O23.x): Dysuria, frequency, urgency, hematuria (cystitis); flank pain, CVA tenderness, fever, nausea (pyelonephritis); asymptomatic bacteriuria on urine culture ≥10⁵ CFU/mL.
• Fetal concerns (O36.x): Decreased fetal movement, abnormal non-stress test (NST), growth restriction on ultrasound, abnormal Doppler velocimetry.
• Amniotic fluid abnormalities (O40/O41): Polyhydramnios: fundal height > dates, fetal malpresentation; Oligohydramnios: decreased fundal height, AFI <5 cm on ultrasound.
• Placental disorders (O43–O45): Painless vaginal bleeding (placenta previa); painful vaginal bleeding with uterine rigidity/tenderness (abruption); abnormal placental location on ultrasound.
• Early hemorrhage (O20.x): Vaginal bleeding in first trimester; pelvic cramping; threatened vs. inevitable vs. complete abortion.

🧭 Differential Diagnosis

📋 Clinical Indicators for Coders/CDI

The following table summarizes key documentation elements that drive code specificity and CDI query triggers for common pregnancy conditions:

🦴 Anatomy & Pathophysiology

Hypertensive Disorders of Pregnancy: Abnormal placentation with inadequate trophoblastic invasion leads to reduced uteroplacental perfusion. This triggers systemic endothelial dysfunction, vasoconstriction, and activation of the coagulation cascade. In preeclampsia, antiangiogenic factors (sFlt-1, sEng) are released, causing proteinuria, end-organ damage, and, in severe cases, HELLP syndrome or eclamptic seizures (ACOG Practice Bulletin 222).

Gestational Diabetes: Normal pregnancy increases insulin resistance due to human placental lactogen, cortisol, and progesterone. When pancreatic beta-cell compensation is inadequate, GDM develops. Poorly controlled GDM leads to fetal hyperinsulinemia, macrosomia, neonatal hypoglycemia, and long-term metabolic risks for the mother (ACOG Practice Bulletin 190).

Venous Complications: Pregnancy increases blood volume by ~45%, progesterone causes venous dilation and reduced tone, and uterine compression of pelvic veins increases venous pressure in the lower extremities — contributing to varicose veins, superficial thrombophlebitis, and markedly elevated DVT/PE risk.

GU Infections: Progesterone-induced ureteral dilation (physiologic hydronephrosis), bladder compression, and glycosuria create favorable conditions for bacterial ascent. Untreated asymptomatic bacteriuria progresses to pyelonephritis in 25–40% of pregnant patients if untreated (ACOG Practice Bulletin 219).

Placental Disorders: Placenta previa results from implantation over or near the internal cervical os. Placental abruption involves premature separation of a normally implanted placenta from the uterine wall, causing hemorrhage into the decidua basalis, potential fetal hypoxia, and maternal coagulopathy (DIC) in severe cases.

Fetal Growth Restriction: Results from uteroplacental insufficiency (most common), fetal chromosomal anomalies, infections (TORCH), or maternal medical conditions. Doppler velocimetry of the umbilical artery is the key monitoring tool — absent or reversed end-diastolic flow indicates severe compromise.

💊 Medication Impact / Treatment

Medications used in pregnancy conditions have direct coding and reimbursement implications:

• Labetalol, nifedipine, hydralazine: First-line antihypertensives in pregnancy. IV labetalol/hydralazine used for acute severe hypertension. Document indication (gestational HTN vs. preeclampsia vs. chronic HTN) to support O10–O16 codes.
• Magnesium sulfate: Seizure prophylaxis in preeclampsia with severe features; eclampsia treatment. Its use is a strong CDI trigger for querying severity of preeclampsia.
• Betamethasone (J0702): Antenatal corticosteroid given for fetal lung maturity when preterm delivery is anticipated (23–34 weeks). Two doses 24 hours apart IM. Directly supports coding of preterm labor/delivery codes and documentation of gestational age (Z3A.xx).
• 17-Alpha Hydroxyprogesterone Caproate / 17-OHPC (J1725): Used for prevention of recurrent preterm birth in patients with a prior spontaneous preterm birth. Weekly IM injections from 16–36 weeks. Supports O26.x and Z34.x coding. Note: FDA withdrew approval for Makena brand in 2023; compounded 17-OHPC continues to be used at provider discretion.
• Metformin / Glyburide / Insulin: GDM management. Code specificity depends on whether GDM is diet-controlled (O24.410), or controlled by oral hypoglycemics (O24.415) or insulin (O24.414). Insulin use adds Z79.4 (long-term insulin use) per guidelines.
• Antibiotics (nitrofurantoin, cephalexin, amoxicillin-clavulanate, ceftriaxone): GU infection treatment. IV antibiotics for pyelonephritis often require or support inpatient admission, impacting DRG assignment.
• Progesterone (vaginal suppositories): Used for cervical shortening/threatened preterm labor; supports O34.3x (cervical incompetence) or O60.x (preterm labor) coding.
• Heparin / LMWH (enoxaparin): DVT prophylaxis and treatment in pregnancy; supports O22.2x (deep phlebothrombosis) codes; add Z79.01 (long-term anticoagulant use).

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides

📘 ICD-10-CM Guidelines (FY2026)

Per CMS FY2026 ICD-10-CM Official Guidelines Section I.C.15, the following rules govern Chapter 15 coding:

• Trimester coding: Assign the trimester character based on the trimester of the encounter, not the trimester when the condition first arose. If the provider does not document the trimester, use the unspecified trimester character (0). Document weeks of gestation with Z3A.xx as a secondary code.
• Final character for fetus: For conditions affecting specific fetuses in multiple gestations (O30–O48), assign the appropriate final character (1–5 for fetus affected, 9 for unspecified). Use additional code from O30.1x–O30.9x for multiple gestation.
• Pre-existing conditions: Codes in O10–O11 (chronic HTN, superimposed preeclampsia) require an additional code for the type of hypertension (I10, I12, I13, etc.) per instructional notes.
• Gestational DM and insulin use: When GDM is treated with insulin, assign O24.414 (1st trimester), O24.424 (2nd), O24.434 (3rd), and add Z79.4 (long-term insulin use). Do NOT assign an additional code from category E11 for GDM.
• Postpartum period: Chapter 15 codes are applicable for 6 weeks postpartum. After 6 weeks, use general medical codes. The postpartum period begins immediately after delivery.
• Fetal conditions (O36.x): These codes are assigned on the maternal record only; the fetal condition is documented as the REASON for the maternal encounter, not as a condition of the fetus.
• Z34.x — Supervision of normal pregnancy: Use as a standalone code or with Z3A.xx. Do NOT assign O-codes for complications when the patient is being seen for normal prenatal supervision. If a complication is identified, code the complication rather than Z34.x.
• Prior cesarean scar (O34.21x): Always assign when the patient has a prior cesarean delivery and is currently pregnant, regardless of planned delivery mode. The final character indicates the type of prior uterine incision (1 = low transverse, 2 = low vertical, 3 = classical, 4 = T-shaped/other, 9 = unspecified).
• Hemorrhage codes (O20, O44–O46): Distinguish early pregnancy hemorrhage (O20.x, under 22 weeks) from antepartum hemorrhage (O46.x). O44.x and O45.x are placenta previa and abruption — these specify hemorrhage status in the code descriptor.
• O99.x — Other maternal diseases: These codes are used when conditions classified elsewhere (anemia, thyroid disease, mental health disorders) complicate or are complicated by pregnancy. The underlying condition is coded first when required by instructional notes.

🔢 ICD-10-CM Code Set (FY2026)

🔎 Indexing

Use the ICD-10-CM Alphabetic Index lead terms to locate pregnancy-related codes:

🏥 CPT (2026)

The following CPT codes are used for antepartum, intrapartum, and surveillance services in pregnancy (AMA CPT 2026):

🧾 HCPCS (2026)

📚 AHA Coding Clinic (Recent Guidance)

The following AHA Coding Clinic guidance is particularly relevant to common pregnancy condition coding:

• Superimposed preeclampsia on chronic HTN (O11.x): Coding Clinic has clarified that when a patient with documented chronic hypertension develops new proteinuria or worsening of BP/proteinuria after 20 weeks, code O11.x (with applicable trimester) is appropriate, along with an additional code for the type of chronic hypertension. Query the provider if documentation is ambiguous between chronic HTN exacerbation and superimposed preeclampsia.
• HELLP syndrome: Coding Clinic confirms HELLP syndrome is classified at O14.2x. When HELLP occurs, do NOT separately code hemolysis, elevated liver enzymes, or thrombocytopenia — these are integral to the HELLP syndrome code. Code any sequelae separately (e.g., DIC: O45.001).
• GDM treatment specificity: Coding Clinic has emphasized querying for GDM control method (diet, oral agent, or insulin) as this impacts code assignment and DRG weight. Documentation of “managed with diet and exercise” supports O24.410; glyburide or metformin use supports O24.415; any insulin use — including sliding scale — supports O24.414.
• Previous cesarean scar (O34.21x): Coding Clinic has confirmed this code is assigned in every subsequent pregnancy regardless of planned delivery route (VBAC or repeat C-section). The type of prior incision (low transverse, classical, etc.) should be documented in the operative note or history, and queried if not specified.
• Fetal Growth Restriction vs. SGA: Coding Clinic distinguishes FGR (O36.51x–O36.59x) as a pathological process from small-for-gestational-age (SGA) without specific cause. When the provider documents FGR, use O36.5xx; when the documentation only indicates SGA without an underlying cause established, query for clarification before assigning FGR.
• Z3A weeks-of-gestation: Coding Clinic has confirmed that Z3A codes are assigned as secondary codes with any Chapter 15 code as principal diagnosis. They should reflect the gestational age at the time of the encounter, not the estimated due date.

💰 HCC / Risk Adjustment (v28)

Under the CMS-HCC Model v28 (effective 2024, fully phased in by 2026), most pregnancy-specific (Chapter 15) codes are non-HCC because maternal conditions are episodic and typically resolve. However, when pre-existing chronic conditions complicate or are complicated by pregnancy, those chronic condition codes (assigned alongside the Chapter 15 codes) retain their HCC mapping.

✍️ CDI Query Templates

All queries below are written per ACDIS/AHIMA CDI query best practices — non-leading, multiple-choice, and clinically relevant:

🧑‍⚕️ Treatments (Clinical)

Clinical management of common pregnancy conditions follows evidence-based guidelines. Documentation of treatment decisions supports code specificity:

• Hypertensive Disorders: Mild gestational HTN/preeclampsia — outpatient monitoring, oral antihypertensives (nifedipine, labetalol), twice-weekly NSTs and weekly biophysical profiles. Severe preeclampsia — hospitalization, IV magnesium sulfate, IV antihypertensives (labetalol, hydralazine, nicardipine), planned delivery based on gestational age per ACOG Practice Bulletin 222. Eclampsia — IV magnesium sulfate, delivery after stabilization.
• GDM: Medical nutrition therapy (MNT) for all; oral agents (metformin, glyburide) or insulin if glycemic targets not met. Fasting glucose goal <95 mg/dL; 1-hour postprandial <140 mg/dL. Induction at 39–40 weeks for diet-controlled; 39 weeks or earlier for medication-requiring per ACOG PB 190.
• GU Infections: Asymptomatic bacteriuria — 3–7-day oral antibiotic course (nitrofurantoin, cephalexin, amoxicillin-clavulanate) and test-of-cure. Cystitis — same oral antibiotics. Pyelonephritis — IV antibiotics (ceftriaxone), hospitalization typically required, oral step-down after afebrile 24–48h per ACOG PB 219.
• Placenta Previa: Pelvic rest, hospitalization for significant bleeding, antenatal corticosteroids if <34 weeks, planned cesarean delivery. Bed rest not routinely recommended. Transfusion threshold varies by hemorrhage severity.
• Placental Abruption: Management depends on severity and gestational age — expectant management for mild abruption remote from term; immediate delivery for severe abruption. DIC management with blood product transfusion. Emergency cesarean for category III fetal heart rate tracing.
• Fetal Growth Restriction: Increased antenatal surveillance — serial growth ultrasounds every 2–4 weeks, weekly or twice-weekly NSTs, Doppler velocimetry. Delivery timing based on gestational age and severity of Doppler findings per ACOG PB 227.
• Cervical Incompetence (O34.3x): Cervical cerclage placement (McDonald or Shirodkar technique); progesterone vaginal suppositories 200 mg nightly for cervical length <25 mm; serial transvaginal cervical length monitoring.
• Venous Complications: Compression stockings for varicose veins; LMWH (enoxaparin) for DVT — therapeutic dosing throughout pregnancy and at least 6 weeks postpartum. IVC filter in select cases of recurrent PE or contraindication to anticoagulation.

🎓 Patient Education / Summary

For patients and care teams, key educational points for the most common pregnancy conditions:

• Blood Pressure Monitoring: Patients with gestational hypertension or preeclampsia should monitor BP at home and report readings ≥160/110 or symptoms (severe headache, visual changes, right upper quadrant pain, sudden swelling) immediately. Home BP monitoring is recommended by ACOG for outpatient management of mild preeclampsia.
• Gestational Diabetes: GDM can be managed effectively with diet and monitoring. Patients should understand carbohydrate counting, glucose monitoring (4×/day), and that insulin use does not mean “failure” — it means the pancreas needs support. GDM resolves after delivery in most cases, but 50% will develop T2DM within 10 years — annual glucose screening postpartum is essential.
• Urinary Tract Infections: Pregnant patients should know that UTIs in pregnancy require treatment even without symptoms (asymptomatic bacteriuria), because untreated bacteriuria can progress to kidney infection and preterm labor. Adequate hydration and frequent urination help prevent recurrence.
• Fetal Kick Counts: For patients with fetal growth restriction, polyhydramnios, or placental disorders — daily kick count monitoring (10 movements in 2 hours) is a low-cost early warning tool. Report decreased movement promptly.
• When to Go to Labor and Delivery Immediately: Vaginal bleeding (any amount in 2nd/3rd trimester), severe abdominal pain, decreased fetal movement, severe headache, visual changes, difficulty breathing, or ruptured membranes.
• Prenatal Visits (Z34.x): ACOG recommends a minimum of 8 prenatal visits for low-risk pregnancies. High-risk patients (those with HDP, GDM, fetal concerns) require more frequent visits and additional monitoring.
• Postpartum Follow-up: Patients with preeclampsia/eclampsia require BP monitoring within 3–7 days postpartum and at 6–12 weeks — cardiovascular risk remains elevated. GDM patients require a 75g OGTT 4–12 weeks postpartum per ACOG PB 190.

About this Guide

This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2026 ICD-10-CM (effective October 1, 2025). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.

Last reviewed: April 2026 · Next scheduled review: October 2026 (FY2027 update)